Home Category Region Publishers About Us Contact Us
Home > Market Research Report > Pharmaceutical > Pharmaceutical Companies > Contract Pharmaceutical Manufacturing, Research and Packaging
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Contract Pharmaceutical Manufacturing, Research and Packaging

Published by BCC Research
Published October, 2009 Product code 102343
Content info 187 pages
Price
Not Available

This publication has been discontinued on September 5, 2011.

Below is the updated product.

Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
Published: September, 2011
Product code: 210211

Introduction

Abstract

THIS REPORT:
  • Offers a thorough review of the global market for contract manufacturing, research and packaging in the pharmaceutical business
  • Provides the current global market status for contract manufacturing, research, and packaging and forecasts for growth through 2014
  • Discusses the advantages and disadvantages of outsourcing
  • Covers technological issues including the latest trends and developments
  • Describes the regulatory environment.

STUDY OBJECTIVES

BCC' s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceuticals industry. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceuticals and biotechnology outsourcing industry with the emphasis on contract manufacturing.

This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceuticals industry. The needs, services offered, criteria for selection, and the advantages of outsourcing are discussed. The study also includes the need for project management, market forecasts and a discussion of the market leaders in the industry. Regulatory requirements and current state of the outsourcing market in the pharmaceuticals and biotechnology industry are also portrayed in this report.

A detailed analysis of the pharmaceutical-biopharmaceutical contract manufacturing, research, and packaging industry structure has been conducted. Revenues are broken down by bulk as well as by dosage forms of solid, liquid, and semisolid pharmaceuticals. Sales figures are estimated for the 5 year period from 2009 through 2014.

Over-the-counter (OTC), nutritional, and drug-delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately

SCOPE OF THE STUDY

The scope of this study encompasses the contract manufacturing, research, and packaging markets. BCC analyzes each market and its applications by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

METHODOLOGY

BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical, chemical, pharmaceutical, and contracting experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

Shalini S. Dewan holds a master' s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems; Orthopedic Drugs, Implants and Devices; Imaging Reagents; Regulatory Industry; and Dynamic Sera, Media and Reagents Used in Biotechnology.

Table of Contents

Contract Pharmaceutical Manufacturing, Research and Packaging

Chapter- 1: INTRODUCTION -- Complimentary

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ABOUT THE AUTHOR
  • RELATED BCC RESEARCH REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter-2: SUMMARY

  • SUMMARY
  • SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS)
  • SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

  • DEFINITIONS
  • CONTRACT MANUFACTURING
  • CONTRACT MANUFACTURER
  • TYPES OF CONTRACT MANUFACTURERS
  • CORE COMPETENCIES
  • VENDOR
  • CONTRACT RESEARCH ORGANIZATION (CRO)
  • HISTORY OF OUTSOURCING
  • HISTORY OF OUTSOURCING (CONTINUED)
  • HISTORY OF OUTSOURCING (CONTINUED)

Chapter-4: CONTRACT MANUFACTURING

  • NEED FOR CONTRACT MANUFACTURING
  • FLEXIBILITY
  • CAPACITY AND CAPITAL
  • RISK
  • ADVANTAGES OF CONTRACT MANUFACTURING
    • TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING
    • TABLE 1 (CONTINUED)
  • SELECTION OF CONTRACT MANUFACTURER
  • MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS

Chapter-5: CONTRACT RESEARCH

  • INCLUDED IN RESEARCH
  • DRUG DISCOVERY AND DEVELOPMENT
  • CLINICAL RESEARCH
  • ANALYTICAL RESEARCH
  • NEED FOR CONTRACT RESEARCH
  • SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION
  • SELECTION AND MANAGEMENT OF CRO

Chapter-6: CONTRACT PACKAGING

  • CONTRACT PACKAGING
  • THE NEED FOR CONTRACT PACKAGING
  • CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE
  • LOCATION
  • EXPERIENCE
  • PERSONALITY
  • FINANCIAL STRENGTH
  • ADVANTAGES OF CONTRACT PACKAGING
  • ADVANTAGES OF CONTRACT PACKAGING (CONTINUED)

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

  • PROJECT EVALUATION AND SET UP
  • PLANNING AND EXECUTION
  • QUALITY MANAGEMENT
  • MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT' S PERSPECTIVE
  • MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE
  • Management of Quality Components ... (Continued)

Chapter-8: REGULATORY ASPECTS

  • SHORT SUPPLY ARRANGEMENTS
  • DIVIDED MANUFACTURING ARRANGEMENTS
  • SHARED MANUFACTURING ARRANGEMENTS
  • RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER
  • CONTRACT MANUFACTURING ARRANGEMENTS
  • RESPONSIBILITIES OF LICENSED MANUFACTURER
    • TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS
  • RESPONSIBILITIES OF THE CONTRACT MANUFACTURER
  • WARNING LETTERS
  • WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS
  • Warning Letters Issued to ... (Continued)
  • APPROVALS OF MANUFACTURING FACILITIES

Chapter-9: INDUSTRY STRUCTURE

  • MARKET SHARES OF INDUSTRY LEADERS
  • CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS
    • TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
    • FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)
  • CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
    • TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
    • TABLE 4 (CONTINUED)
    • FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)
  • CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
  • NONSTERILE
    • TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
    • FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • STERILE
    • TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
    • TABLE 6 (CONTINUED)
    • FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)
  • CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
    • TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
    • FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)
  • CONTRACT RESEARCH COMPANIES
    • TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
    • FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)
  • CONTRACT PACKAGING COMPANIES
    • TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
    • FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)
  • TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
    • TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 10 (CONTINUED)
    • TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

Chapter-10: TECHNOLOGY TRANSFER

  • REASONS FOR TECHNOLOGY TRANSFER
  • CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
  • PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER
  • STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
  • TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
  • CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
  • MATERIAL TRANSFER AGREEMENT (MTA)
  • ASSIGNMENT DEED
  • LICENSE AGREEMENT
  • CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
  • FACTORS FOR A SUCCESSFUL PROJECT
  • FACTORS FOR A SUCCESSFUL PROJECT (CONTINUED)

Chapter-11: NEW DEVELOPMENTS

  • QUINTILES INC.
  • COVANCE
  • CHARLES RIVER LABORATORIES
  • OTHERS
  • OTHERS (CONTINUED)
  • OTHERS (CONTINUED)

Chapter-12: MARKETS

  • CONTRACT MANUFACTURING
  • CONTRACT MANUFACTURE OF BULK DRUGS/APIS
  • Market Overview
  • Market Overview (Continued)
  • Market Revenue
    • TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
  • Market Shares
    • TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
  • Solid Dosage Formulations
  • Market Overview
  • Market Revenue
    • TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
  • Market Shares
    • TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Market by Formulation
  • Market Revenue
    • TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS)
    • TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
    • FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%)
  • Liquid Dosage Formulations
  • Market Overview
  • Market Overview (Continued)
  • Market Overview (Continued)
  • Non-sterile Formulations
  • Market Revenue
    • TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • Market Shares
    • TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)
    • FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Sterile Formulations
  • Market Revenue
    • TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • Market Shares
    • TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Market by Formulation
  • Non-sterile Formulations
    • TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
    • TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
    • FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • Sterile Formulations
    • TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)
    • TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
    • FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
  • Market Overview
  • Market Overview (Continued)
  • Market Revenue
    • TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • Market Shares
    • TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Market by Formulation
    • TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)
    • TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
    • FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)
  • CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
  • Contract Manufacture ...(Continued)
  • Market Overview
    • TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
    • TABLE 30 (CONTINUED)
  • Market Revenue
    • TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
  • Market Shares
    • TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Market by Formulation
    • TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS)
    • FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS)
  • Market Shares
    • TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%)
    • FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%)
  • CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
  • Market Overview
  • Market Revenue
    • TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)
  • Market Shares
    • TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)
  • Market by Formulation
    • TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS)
    • FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS)
    • TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
    • FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)
  • CONTRACT RESEARCH
  • MARKET OVERVIEW
  • Partnerships
  • Partnerships (Continued)
  • Expansions of Facilities
  • MARKET REVENUE
    • TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS)
  • MARKET SHARES
    • TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)
  • MARKET BY DISCIPLINE
    • TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS)
    • FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS)
  • MARKET SHARES BY DISCIPLINE
    • TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
    • FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)
  • CONTRACT PACKAGING
  • MARKET OVERVIEW
  • Market Overview (Continued)
  • MARKET REVENUE
    • TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS)
  • MARKET SHARES
    • TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
    • FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)
  • MARKET BY PACKAGE TYPE
  • MARKET REVENUE
    • TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS)
    • FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS)
  • MARKET SHARES
    • TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)
    • FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

  • CARDIOVASCULAR DRUG MARKET
  • MARKET REVENUE
    • TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • REPRODUCTIVE DRUG MARKET
  • MARKET REVENUE
    • TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • ONCOLOGY DRUG MARKET
  • MARKET REVENUE
    • TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • ANALGESIC MARKET
  • MARKET REVENUE
    • TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • ANTIVIRAL DRUGS MARKET
  • MARKET REVENUE
    • TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • ANTIBIOTICS MARKET
  • MARKET REVENUE
    • TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)
    • FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)
  • MARKETS FOR OTHER DRUGS
  • MARKET REVENUE
    • TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)
    • FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Chapter-14: PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009
    • FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009
    • FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005 - 2009 (%)
  • PATENTS BY COMPANY
    • TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009
  • PATENTS BY COUNTRY
    • TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009
    • TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%)
    • FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)
  • PATENTS BY EMPHASIS
    • TABLE 58 PATENTS BY EMPHASIS, 2005-2009

Chapter-15: CURRENT ENVIRONMENT

  • OVERALL SITUATION OF THE CONTRACTING MARKET
  • CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
  • CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
  • CONTRACT RESEARCH
  • CONTRACT PACKAGING
  • SUCCESS FACTORS FOR CMOS
  • PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET
  • FROM THE PHARMACEUTICAL COMPANIES' PERSPECTIVE
  • FROM CONTRACT MANUFACTURING ORGANIZATION' S PERSPECTIVE
  • FACTORS AFFECTING THE OUTSOURCING MARKET
  • COST CONTAINMENT
  • GLOBALIZATION
  • MERGERS AND ACQUISITIONS
  • REGULATORY REQUIREMENTS
  • NEED FOR SPECIALIZED SERVICES
  • COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY
  • INTRODUCTION OF NEW BIOTHERAPEUTICS

Chapter-16: COMPANY PROFILES

  • AAI PHARMA, INC.
  • ABBOTT LABORATORIES
  • AEROGEN, INC.
  • ALBANY MOLECULAR RESEARCH, INC.
  • ALCAN PACKAGING
  • ALKERMES, INC.
  • AMERISOURCE BERGEN
  • A. P. PHARMA, INC.
  • ARADIGM CORPORATION
  • BAXTER HEALTHCARE
  • BEN VENUE LABORATORIES INC.
  • BIOVAIL CORP.
  • BOEHRINGER INGELHEIM
  • BOOTS MANUFACTURING
  • CAMBREX CORP.
  • CANGENE
  • CATALENT PHARMA SOLUTIONS
  • CEDARBURG HAUSER PHARMACEUTICAL LTD.
  • CENEXI
  • CHARLES RIVER LABORATORIES
  • CHEMBRIDGE CORP.
  • CONFAB LABORATORIES
  • COVANCE INC.
  • DAVOS PHARMA
  • DECODE GENETICS
  • DIOSYNTH BIOTECHNOLOGY
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
  • DOW CHEMICAL COMPANY
  • DPT LABORATORIES INC.
  • DR REDDY' S LABORATORIES
  • DSM PHARMACEUTICAL PRODUCTS
  • ELAN DRUG TECHNOLOGIES
  • EVOTEC AG
  • FULCRUM PHARMA PLC
  • GENZYME PHARMACEUTICALS
  • GIRINDUS AG
  • GLAXOSMITHKLINE BIOPHARMACEUTICALS
  • HOVIONE S.A.
  • JUBILANT ORGANOSYS
  • KENDLE INTERNATIONAL INC.
  • KING PHARMACEUTICALS
  • KP PHARMACEUTICAL TECHNOLOGIES INC
  • K.V. PHARMACEUTICAL CO.
  • LIGAND PHARMACEUTICALS
  • LONZA GROUP
  • LYNE LABORATORIES
  • MALLINCKRODT
  • MDS PHARMA SERVICES
  • MEDAREX INC.
  • MIKART INC
  • NORWICH PHARMACEUTICALS
  • NOVAVAX, INC.
  • OMNICARE CLINICAL RESEARCH
  • PAREXEL INTERNATIONAL CORPORATION
  • PATHEON INC.
  • PERRIGO COMPANY
  • PHARMACEUTICAL PRODUCT DEVELOPMENT INC.
  • PIRAMAL HEALTHCARE
  • PRA INTERNATIONAL
  • QUINTILES
  • RANBAXY RESEARCH LABS
  • REGIS TECHNOLOGIES, INC.
  • SCHWARZ PHARMA AG
  • SKYEPHARMA
  • TALECRIS BIOTHERAPEUTICS INC.
  • WUXI APP TEC
  • XCELLEREX, LLC
  • APPENDIX : ABBREVIATIONS
  • APPENDIX
  • APPENDIX (CONTINUED)
Back to Top